Platelet 'decoys' outsmart both clots and cancer
Deactivated platelets offer a potential drug-free, reversible antiplatelet therapy Heart disease, stroke, sepsis, and cancer collectively cause the greatest number of deaths worldwide. They also...
NEWS INDEX
Scientists discover how neuroactive steroids dampen inflammatory signaling in cells
The research, published in Scientific Reports, shows how new compounds could target specific brain cell receptors to treat a wide variety of conditions, such as...
Study shows endocrine-disrupting chemicals linked to equine metabolic syndrome
Credit: University of Minnesota College of Veterinary Medicine Endocrine-disrupting chemicals (EDCs) in a horse's environment may play a role in the development of equine metabolic...
Mount Sinai research program awarded $12.5 million NIH grant to continue to study the role of hormones in menopause and aging biology
Researchers from the Icahn School of Medicine at Mount Sinai have been awarded a $12.5 million grant from the National Institute on Aging, part of...
In the squirrel world, prime real estate is determined by previous owner, study reveals
Researchers found male squirrels store more food than females, and if a young squirrel leaving the nest nabs a storage spot previously owned by a...
IU School of Medicine makes breakthrough toward developing blood test for pain
Credit: Indiana University School of Medicine INDIANAPOLIS--A breakthrough test developed by Indiana University School of Medicine researchers to measure pain in patients could help stem...
More scrutiny needed for less-deadly foodborne bacteria
Credit: Penn State Employing advanced genetic-tracing techniques and sharing the data produced in real time could limit the spread of bacteria -- Bacillus cereus --...
POPULAR NEWS
-
Insilico Medicine receives IND approval from FDA for novel MAT2A inhibitor ISM3412
-
San Antonio-based SwRI to construct first facility outside of Texas
-
Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinoma
-
Professor Miguel Ángel García receives the prestigious ERC Advanced Grant from the European Research Council